Evaluating the effectiveness of telehealth lifestyle therapy versus telehealth psychotherapy for reducing depression in adults with COVID-19 related distress: The CALM trial

Deakin University0 个研究点目标入组 182 人开始时间: 2021年4月8日最近更新: 2022年12月5日

适应症

试验速览

暂无简介。

•1. Are 18 years or older
•2. Have a Distress Questionnaire-5 (DQ5) score >8 at enrolment
•3. Are deemed suitable by a treating clinician for participation in a structured lifestyle or psychotherapy program for 8 weeks
•4. Are willing to commit to six 90-minute sessions over an eight-week period
•5. Are willing to provide blood and stool samples on two occasions
•6. Have basic computer and internet literacy
•7. Have capacity to provide informed consent and converse in English

•1. Aged <18 years
•2. No/low distress (DQ5 score <8); or in crisis or suicidal at time of enrolment (as determined by treating clinician and/or case manager)
•3. Known or suspected clinically unstable systemic medical disorder
•4. Severe food allergies, intolerances, aversions or malabsorption issues
•5. Medically unfit to engage in an exercise program (may be determined by treating clinician)
•6. Pregnant, breastfeeding, or planning pregnancy within the next year
•7. Socio-cultural, religious, medical reasons precluding participation in a lifestyle intervention
•8. Commencement of a new, duplicating treatment (e.g. psychotherapy) for a mental illness within a one-month period prior to baseline OR continuing symptoms which are treatment resistant on medication.
•9. Participation in another study that involves an intervention
•10. Current or history of an eating disorder

发起方